Identification of secreted proteins important for tularemia pathogenesis
Identification of secreted proteins important for tularemia pathogenesis
批准号:
7267993
负责人:
Martin S. Pavelka
金额:
$18.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2009-01-31
关键词:
AerosolsAttenuated Live Virus VaccineAttenuated VaccinesBacteriaBiologicalBiologyCategoriesCell LineCenters for Disease Control and Prevention (U.S.)ComplementContainmentDevelopmentDiagnosticDiseaseDisruptionExploratory/Developmental Grant for Diagnostic Cancer ImagingFrancisellaFrancisella tularensisFundingFutureGenesGeneticGoalsGram-Negative BacteriaIn VitroLaboratoriesLactamaseMethodsMusMutagenesisNational Institute of Allergy and Infectious DiseaseNatureOrganismPathogenesisPhenotypePhysiologyPlasmidsProteinsPublic HealthReporterResearchResistanceRouteSeveritiesSystemTestingTularemiaVaccinesVirulenceVirulentWorkbasebiodefensedrug developmentinterestmacrophagemouse modelmutantpathogentool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Gram-negative bacterium Francisella tularensis subsp. tularensis, the causative agent of tularemia, is considered a potentially dangerous biological weapon. This is due to the organism's extreme infectivity via the aerosol route and the severity of tularemia. The fastidious nature of the bacterium, the requirement that it be handled using biosafety level three (BSL3) containment, and the paucity of genetic tools have hindered research on this organism. Thus, compared to many other bacterial pathogens, little is known about F. tularensis subsp. tularensis physiology, genetics, and pathogenesis. Previous studies have used the attenuated live vaccine strain (LVS) derived from F. tularensis subsp. holarctica, or the rarely pathogenic F. tularensis subsp. novicida. The goal of this proposal is to identify secreted proteins that are important in the pathogenesis of the virulent F. tularensis subsp. tularensis. We will use recently developed genetic tools to identify and disrupt genes encoding secreted proteins with the immediate goal of identifying proteins required for intracellular survival and replication in mouse macrophages. We anticipate that this work will identify several proteins of interest and will allow us to formulate hypotheses for the basis of further work. The work proposed in this application would contribute to the research goals of the NIAID biodefense research agenda for CDC category A agents such as Francisella tularensis. These immediate goals include; 1) the development of genetic systems to correlate differences in pathogenesis and virulence and 2) increased diversity of expertise in the study of tularemia.
The research in this proposal will provide additional genetic methods for the study of F. tularensis biology and identify factors important for the pathogenesis of tularemia disease. This work may also contribute to better diagnostics, vaccine and drug development. Because of F. tularensis is a select agent and could be used a biological weapon, this research could potentially have a significant impact on public health in the future.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Another brick in the wall.
在墙上的另一块砖。
DOI:
10.1016/j.tim.2007.02.003
发表时间:
2007
期刊:
Trends in microbiology
影响因子:
15.9
作者:
[PavelkaJr,MartinS]
通讯作者:
PavelkaJr,MartinS
DOI:
10.1007/978-1-59745-232-8_14
发表时间:
2008
期刊:
Methods in molecular biology
影响因子:
--
作者:
[M. Pavelka]
通讯作者:
M. Pavelka
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
-
批准号:10350750
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2022
-
负责人:Martin S. Pavelka
-
依托单位:
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
-
批准号:10608077
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2022
-
负责人:Martin S. Pavelka
-
依托单位:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
-
批准号:10203747
-
项目类别:
-
资助金额:$44.15万
-
财政年份:2018
-
负责人:Martin S. Pavelka
-
依托单位:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
-
批准号:10431963
-
项目类别:
-
资助金额:$44.15万
-
财政年份:2018
-
负责人:Martin S. Pavelka
-
依托单位:
New tools for studying M. abscessus pathogenesis
-
批准号:8814644
-
项目类别:
-
资助金额:$27.35万
-
财政年份:2015
-
负责人:Martin S. Pavelka
-
依托单位:
New tools for studying M. abscessus pathogenesis
-
批准号:9107388
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2015
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:8079716
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:8296659
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:7629629
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:7888312
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Assembly of the mycobacterial cell wall
-
批准号:7531380
-
项目类别:
-
资助金额:$39.58万
-
财政年份:2008
-
负责人:Martin S. Pavelka
-
依托单位:
Genetic screens to identify mycobacterial porins
-
批准号:7497121
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2007
-
负责人:Martin S. Pavelka
-
依托单位:
Genetic screens to identify mycobacterial porins
-
批准号:7204287
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:Martin S. Pavelka
-
依托单位:
Identification of secreted proteins important for tulremia pathogenesis
-
批准号:7146725
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2006
-
负责人:Martin S. Pavelka
-
依托单位:
Development of genetic tools for Francisella tularensis
-
批准号:6665998
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2003
-
负责人:Martin S. Pavelka
-
依托单位:
Development of genetic tools for Francisella tularensis
-
批准号:6776437
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2003
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6259328
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6612993
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6532810
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位:
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
-
批准号:6374472
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2000
-
负责人:Martin S. Pavelka
-
依托单位: